Jacquelyn Sumer - Aug 15, 2022 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Chief Legal Officer
Signature
/s/ Jacquelyn L Sumer
Stock symbol
CGEM
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 05:07 PM
Previous filing
Jun 2, 2022
Next filing
Feb 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Award $0 +190K $0.00 190K Aug 15, 2022 Common Stock 190K $14.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 190,000 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on August 15, 2023, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.